Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,745,268
+$3,626,244 QoQ
Shares Held
81,632
+323.9% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#103
of 329 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,094,353,895 across 113 Biotechnology names. PCVX ranks #35 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
139,233 | $69,161,207 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
397,000 | $52,693,809 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in PCVX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,745,268 | 81,632 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,119,024 | 19,257 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,179,645 | 68,913 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,821,189 | 244,897 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $958,881 | 29,495 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,141,635 | 30,234 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,658,992 | 142,426 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,662,741 | 14,551 | Shares | Defined | 2024-11-14 | |
| 2023-03-31 | $955,439 | 25,492 | Principal | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||